BioGene Therapeutics Inc. research brief

CIK 2140719 Copy CIK

Generated Nov. 2, 2026, 11:14 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: AUSTIN TX. Reported legal jurisdiction: TEXAS. These do not establish investor residence or where funds were deployed.

• Aug. 7, 2026 · D · 0002140719-26-000005 · Source evidence

  Reported offering amount: 3000000 USD. Reported amount sold: 3000000 USD.

• Aug. 6, 2026 · D · 0002140719-26-000004 · Source evidence

  Reported offering amount: 3000000 USD. Reported amount sold: 3000000 USD.

• Aug. 6, 2026 · D · 0002140719-26-000003 · Source evidence

  Reported offering amount: 250000 USD. Reported amount sold: 250000 USD.

• Aug. 6, 2026 · D · 0002140719-26-000002 · Source evidence

  Reported offering amount: 250000 USD. Reported amount sold: 250000 USD.

• July 23, 2026 · D · 0002140719-26-000001 · Source evidence

  Reported offering amount: 4550000 USD. Reported amount sold: 4550000 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “BioGene Therapeutics Inc. research brief,” CIK 2140719, retrieved Nov. 2, 2026, 11:14 a.m.. Cite the specific accessions used. No amounts have been summed.